Neogen Chemicals Peer Comparison
NSE: NEOGEN | BSE: 542665
₹2,209.80
As on 28-Aug-2026IST
Market cap
₹6,051 Cr
Revenue (TTM)
₹926 Cr
P/E Ratio
170.2
P/B Ratio
6.1
Div. Yield
0 %
| Neogen Chemicals | Atul | DCM Shriram | EID Parry | India Glycols | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
6,051 | 19,006 | 15,936 | 14,332 | 7,891 |
Revenue (₹ Cr) |
926 | 6,643 | 14,593 | 38,840 | 10,312 |
Net Profit (₹ Cr) |
35.13 | 804.37 | 1,434.33 | 1,227.53 | 267.94 |
Net Margin (%) |
3.76 | 11.74 | 9.69 | 3.14 | 2.60 |
RoE (%) |
4.40 | 13.10 | 16.37 | 16.62 | 11.90 |
Price to Earnings |
170.16 | 23.89 | 11.12 | 30.83 | 24.95 |
Price-To-Book |
6.09 | 2.94 | 1.90 | 1.58 | 2.62 |
Income Statement (₹ Cr)
| Neogen Chemicals | Atul | DCM Shriram | EID Parry | India Glycols | |
|---|---|---|---|---|---|
|
Operating Revenue
|
925.53 | 6,643.49 | 14,593.40 | 38,839.87 | 10,311.95 |
|
Total Income
|
934.35 | 6,853.46 | 14,795.13 | 39,129.45 | 10,315.86 |
|
Total Expenditure
|
771.53 | 5,454.66 | 13,063.01 | 35,444.92 | 9,642.78 |
|
EBITDA
|
154.00 | 1,188.83 | 1,530.39 | 3,394.95 | 669.17 |
|
Depreciation
|
29.94 | 318.18 | 519.19 | 830.24 | 163.41 |
|
EBIT
|
124.06 | 870.65 | 1,011.20 | 2,564.71 | 505.76 |
|
Interest
|
83.27 | 16.91 | 172.71 | 465.10 | 147.68 |
|
Other Income
|
8.82 | 209.97 | 201.73 | 289.58 | 3.91 |
|
Exceptional Items
|
0.00 | 0.00 | 56.03 | -478.38 | -0.83 |
|
Profit before Tax
|
49.61 | 1,063.71 | 1,096.25 | 1,910.81 | 361.16 |
|
Provision for Tax
|
14.48 | 259.34 | -338.08 | 683.28 | 93.22 |
|
Profit after Tax
|
35.13 | 804.37 | 1,434.33 | 1,227.53 | 267.94 |
Liabilities (₹ Cr)
| Neogen Chemicals | Atul | DCM Shriram | EID Parry | India Glycols | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
816.25 | 6,221.96 | 7,711.97 | 8,766.12 | 2,932.78 |
|
Minority Interest
|
0.00 | -15.53 | -2.78 | -762.63 | 0.00 |
|
Non-Current Liabilities
|
897.95 | 481.91 | 2,678.72 | 1,126.98 | 1,576.06 |
|
Current Liabilities
|
1,187.67 | 1,122.05 | 3,725.20 | 13,207.34 | 2,014.11 |
|
Total Liabilities
|
2,901.87 | 8,031.35 | 16,276.68 | 29,211.55 | 6,522.95 |
Assets (₹ Cr)
| Neogen Chemicals | Atul | DCM Shriram | EID Parry | India Glycols | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
1,268.64 | 3,738.40 | 8,228.02 | 9,527.28 | 4,875.38 |
|
Current Assets
|
1,392.51 | 4,055.60 | 5,564.08 | 18,746.53 | 1,497.81 |
|
Total Assets
|
2,901.87 | 8,031.35 | 16,276.68 | 29,211.55 | 6,522.95 |
|
Total Debt*
|
1,329.89 | 179.76 | 2,812.49 | 2,854.14 | 1,578.47 |
|
Net Current Assets
|
204.84 | 2,933.55 | 1,838.88 | 5,539.19 | -516.30 |
|
Contingent Liabilities
|
156.69 | 162.71 | 78.08 | 497.03 | 44.50 |
Cashflow (₹ Cr)
| Neogen Chemicals | Atul | DCM Shriram | EID Parry | India Glycols | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-231.48 | 1,022.77 | 1,233.80 | 1,541.51 | 769.16 |
|
Cash Flow from Investing Activities
|
-410.26 | -894.55 | -1,240.63 | -173.91 | -766.68 |
|
Cash from Financing Activities
|
641.71 | -98.46 | -306.83 | -550.88 | 22.54 |
|
Net Cash Inflow / Outflow
|
-0.03 | 29.76 | -313.66 | 816.72 | 25.03 |
Ratios
Profitability Ratios
| Neogen Chemicals | Atul | DCM Shriram | EID Parry | India Glycols | |
|---|---|---|---|---|---|
|
ROCE (%)
|
6.64 | 15.05 | 11.72 | 23.60 | 12.73 |
|
ROE (%)
|
4.40 | 13.10 | 16.37 | 16.62 | 11.90 |
|
ROA (%)
|
1.51 | 10.80 | 10.68 | 4.58 | 4.22 |
|
EBIT Margin (%)
|
13.40 | 13.11 | 6.93 | 6.60 | 4.90 |
|
Net Margin (%)
|
3.76 | 11.74 | 9.69 | 3.14 | 2.60 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Neogen Chemicals | Atul | DCM Shriram | EID Parry | India Glycols | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
18.00 | 15.75 | 11.20 | 15.66 | 11.37 |
|
EBIT Growth (%)
|
12.50 | 44.40 | 6.38 | 5.20 | 22.48 |
|
Net Profit Growth (%)
|
5.15 | 57.96 | 132.17 | -40.10 | 41.40 |
|
EPS Growth (%)
|
-18.73 | 59.14 | 97.98 | 60.42 | -38.92 |
|
Book Value Growth (%)
|
3.41 | 11.14 | 10.11 | 10.53 | 30.01 |
Valuation Ratios
| Neogen Chemicals | Atul | DCM Shriram | EID Parry | India Glycols | |
|---|---|---|---|---|---|
|
Price / Earnings
|
166.88 | 23.89 | 13.04 | 9.90 | 24.48 |
|
Price / Book Value
|
6.09 | 2.94 | 1.90 | 1.58 | 2.62 |
|
Dividend Yield (%)
|
0.05 | 0.46 | 1.10 | 0.00 | 0.64 |
|
EV/EBITDA
|
47.90 | 14.67 | 11.65 | 4.08 | 14.08 |
|
Market Cap (₹ Cr)
|
2,933.68 | 18,762.28 | 17,435.78 | 13,791.35 | 5,690.46 |
Solvency Ratios
| Neogen Chemicals | Atul | DCM Shriram | EID Parry | India Glycols | |
|---|---|---|---|---|---|
|
Debt to Equity
|
1.00 | 0.03 | 0.21 | 0.02 | 0.31 |
|
Short term debt to equity ratio
|
0.51 | 0.00 | 0.13 | 0.29 | 0.13 |
|
Current Ratio
|
1.17 | 3.61 | 1.49 | 1.42 | 0.74 |
|
Quick Ratio
|
0.69 | 2.89 | 0.66 | 0.76 | 0.30 |
|
Interest Coverage
|
1.60 | 63.90 | 7.35 | 5.11 | 3.45 |
Operating Efficiency Ratios
| Neogen Chemicals | Atul | DCM Shriram | EID Parry | India Glycols | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
41.10 | 19.13 | 7.41 | 6.08 | 3.41 |
|
Asset Turnover
|
0.40 | 0.89 | 1.09 | 1.45 | 1.62 |
|
Receivable days
|
122.62 | 67.96 | 24.70 | 19.51 | 13.30 |
|
Inventory Days
|
185.31 | 43.79 | 72.95 | 72.68 | 38.29 |
|
Payable days
|
275.96 | 80.97 | 62.67 | 42.60 | 138.23 |
|
Cash Conversion Cycle
|
31.97 | 30.78 | 34.99 | 49.59 | -86.64 |